Estivill X, Ortigosa L, Pérez-Frias J, Dapena J, Ferrer J, Peña L, Peña L, Llevadot R, Giménez J, Nunes V
Molecular Genetics Department (I.R.O.), Hospital Duran i Reynals, Barcelona, Spain.
Hum Genet. 1995 Mar;95(3):331-6. doi: 10.1007/BF00225203.
We present the genotype/phenotype correlation analysis for 16 cystic fibrosis (CF) patients who carry mutation R334W. Current age and age of diagnosis was significantly higher in the R334W/any-mutation group (P < 0.05 and P < 0.01), compared with the delta F508/delta F508 group. A slightly, but not significantly, worse lung function was found in the R334W/any-mutation group, when compared with the delta F508/delta F508 patients. The proportion of patients with lung colonization with bacterial pathogens was slightly, but not significantly, higher in the R334W/any-mutation group (71.4%), compared with the delta F508/delta F508 or R334W/delta F508 groups (55.5%). None of the R334W patients had meconium ileus but 60% were pancreatic insufficient (PI), a significantly lower proportion (P << 0.001) than delta F508/delta F508 patients. Two R334W/N1303K compound heterozygous sisters of three sibs with genotype R334W/delta F508 showed interfamilial discordant clinical data for lung and pancreatic function. The data provided here for mutation R334W demonstrate that this mutation is responsible for a less severe form of CF than delta F508. Interfamilial differences for PI and lung function suggest that other factors, viz. genetic, environmental and medical, contribute to the wide spectrum of clinical differences observed in CF patients with the same CF transmembrane conductance regulator genotypes.
我们对16名携带R334W突变的囊性纤维化(CF)患者进行了基因型/表型相关性分析。与ΔF508/ΔF508组相比,R334W/任何突变组的当前年龄和诊断年龄显著更高(P < 0.05和P < 0.01)。与ΔF508/ΔF508患者相比,R334W/任何突变组的肺功能略差,但差异不显著。与ΔF508/ΔF508或R334W/ΔF508组(55.5%)相比,R334W/任何突变组中细菌病原体肺部定植患者的比例略高(71.4%),但差异不显著。没有R334W患者发生胎粪性肠梗阻,但60%存在胰腺功能不全(PI),这一比例显著低于ΔF508/ΔF508患者(P << 0.001)。在三个基因型为R334W/ΔF508的同胞中,有两个R334W/N1303K复合杂合子姐妹在肺部和胰腺功能方面表现出家族间不一致的临床数据。这里提供的关于R334W突变的数据表明,与ΔF508相比,该突变导致的CF病情较轻。PI和肺功能的家族间差异表明,其他因素,即遗传、环境和医疗因素,导致了具有相同CF跨膜传导调节因子基因型的CF患者出现广泛的临床差异。